These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27365127)

  • 21. Secondary structural formation of alpha-synuclein amyloids as revealed by g-factor of solid-state circular dichroism.
    Lin XJ; Zhang F; Xie YY; Bao WJ; He JH; Hu HY
    Biopolymers; 2006 Oct; 83(3):226-32. PubMed ID: 16752390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of different isoforms of apoE on aggregation of the α-synuclein protein implicated in Parkinson's disease.
    Emamzadeh FN; Aojula H; McHugh PC; Allsop D
    Neurosci Lett; 2016 Apr; 618():146-151. PubMed ID: 26921451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of reparation of repeat sequences in the human alpha-synuclein on fibrillation ability.
    Sode K; Ochiai S; Kobayashi N; Usuzaka E
    Int J Biol Sci; 2006 Oct; 3(1):1-7. PubMed ID: 17200685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein multistate folding thermodynamics: implications for protein misfolding and aggregation.
    Ferreon AC; Deniz AA
    Biochemistry; 2007 Apr; 46(15):4499-509. PubMed ID: 17378587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and dynamics of the extended-helix state of alpha-synuclein: Intrinsic lability of the linker region.
    Sung YH; Eliezer D
    Protein Sci; 2018 Jul; 27(7):1314-1324. PubMed ID: 29663556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to α-synuclein aggregates.
    Deeg AA; Reiner AM; Schmidt F; Schueder F; Ryazanov S; Ruf VC; Giller K; Becker S; Leonov A; Griesinger C; Giese A; Zinth W
    Biochim Biophys Acta; 2015 Sep; 1850(9):1884-90. PubMed ID: 26028294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
    Kamiyoshihara T; Kojima M; Uéda K; Tashiro M; Shimotakahara S
    Biochem Biophys Res Commun; 2007 Apr; 355(2):398-403. PubMed ID: 17300751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
    Kim YS; Lim D; Kim JY; Kang SJ; Kim YH; Im H
    Biochem Biophys Res Commun; 2009 Oct; 387(4):682-7. PubMed ID: 19622344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
    Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL
    J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic study of the inhibitory activity of Geum urbanum extract against α-Synuclein fibrillation.
    Lobbens ES; Breydo L; Skamris T; Vestergaard B; Jäger AK; Jorgensen L; Uversky V; van de Weert M
    Biochim Biophys Acta; 2016 Sep; 1864(9):1160-1169. PubMed ID: 27353564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.
    Fredenburg RA; Rospigliosi C; Meray RK; Kessler JC; Lashuel HA; Eliezer D; Lansbury PT
    Biochemistry; 2007 Jun; 46(24):7107-18. PubMed ID: 17530780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unravelling the inhibitory activity of Chlamydomonas reinhardtii sulfated polysaccharides against α-Synuclein fibrillation.
    Choudhary S; Save SN; Vavilala SL
    Sci Rep; 2018 Apr; 8(1):5692. PubMed ID: 29632314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
    Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
    Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An extract of the marine alga Alaria esculenta modulates α-synuclein folding and amyloid formation.
    Giffin JC; Richards RC; Craft C; Jahan N; Leggiadro C; Chopin T; Szemerda M; MacKinnon SL; Ewart KV
    Neurosci Lett; 2017 Mar; 644():87-93. PubMed ID: 28237800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease.
    Kardani J; Roy I
    ACS Chem Neurosci; 2015 Sep; 6(9):1613-25. PubMed ID: 26167732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UV-induced selective oxidation of Met5 to Met-sulfoxide leads to the formation of neurotoxic fibril-incompetent α-synuclein oligomers.
    Carmo-Gonçalves P; Pinheiro AS; Romão L; Cortines J; Follmer C
    Amyloid; 2014 Sep; 21(3):163-74. PubMed ID: 24784227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.
    Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE
    J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.